Clinical Trial 22690

• Overview

  Study Title:

  Emshape Engaging Mobile Health for Symptom Monitoring and Health Promotion for Black Women on Endocrine Therapy for Breast Cancer.

  Summary:

  The purpose of the study is to develop and test ways of collecting information about symptoms related to hormone therapy for breast cancer.

  Objective:

  Aim 1: To develop a prototype of the EmSHAPE intervention leveraging feedback from Black women with HR+ breast cancer. Aim 2: To refine and finalize the EmSHAPE protocol and mHealth platform Aim 3: To test feasibility, acceptability, and preliminary efficacy of the EmSHAPE intervention via a pilot randomized clinical trial

• Inclusion Criteria

  • Identify as a Black woman
  • Be age 18 or older
  • Have a diagnosis of Stage 0-III HR+ breast cancer receiving treatment with ET
  • Have no documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., schizophrenia)
  • Be able to speak and read English
  • Be able to provide informed consent
  • Have internet access
  • Must have completed primary breast cancer treatment and have taken ET for at least 1 month but not more than 4 months

• Exclusion Criteria

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.